Clinical Trial Update: MBCT and Escitalopram for Treatment-Resistant Depression in Older Adults [NA]

View source ↗

Summary

The clinical trial evaluating mindfulness-based cognitive therapy (MBCT) plus escitalopram for treatment-resistant depression in older adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Treatment-resistant Depression

Drugs mentioned

• Escitalopram (escitalopram)

Snippet

Sponsor: Yun Zhang | Conditions: Treatment-resistant Depression (TRD) | NA | Status: COMPLETED